Literature DB >> 32643467

ERCP and SARS-COV-2: an urgent procedure that should be immune.

John O'Grady1, Jan Leyden1, Padraic MacMathuna1, Stephen Stewart1, T Barry Kelleher1.   

Abstract

BACKGROUND: Radical changes to clinical and endoscopy practice have been rapidly introduced following the spread of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Urgent endoscopies are, however, intended to proceed as normal with additional personal protective procedures. A perceived reduction in hospital attendances may suggest a number of urgently indicated endoscopic retrograde cholangio-pancreatographies (ERCPs) are being missed. Objectives and
Methods: A review of all ERCPs carried out in a large tertiary referral endoscopy unit under healthcare restrictions was compared to the same time period in previous years. The intention was to determine if ERCPs are proceeding as normal or if there is a difference in referral characteristics.
RESULTS: Under service restrictions (13 March to the end of April 2020), 55 ERCPs were performed compared with 87 ERCPs in 2019. Similar numbers to 2019 were also recorded in the preceding years. One case of coronavirus disease 2019 (COVID-19) was reported in a patient in the days following ERCP, with no cases notified among staff related to endoscopy.
CONCLUSIONS: A reduction in ERCP referrals raises concern that a cohort of patients with significant biliary disease remain undetected. Whether this results in later, and more severe, presentation remains to be seen but a potential surge in such cases could significantly burden all future endoscopy planning services.

Entities:  

Keywords:  COVID-19; Endoscopic retrograde cholangio-pancreatographies; SARS-COV-2; referral difficulties and changes; urgent

Mesh:

Year:  2020        PMID: 32643467     DOI: 10.1080/00365521.2020.1789210

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

Review 1.  Systematic review and meta-analysis of clinical outcomes of COVID-19 patients undergoing gastrointestinal endoscopy.

Authors:  Xiangzhou Tan; Jianping Guo; Zihua Chen; Alfred Königsrainer; Dörte Wichmann
Journal:  Therap Adv Gastroenterol       Date:  2021-08-30       Impact factor: 4.409

2.  Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training.

Authors:  Shiran Esmaily; Chia Chuin Yau; Deepak Dwarakanath; John Hancock; Vikramjit Mitra
Journal:  Frontline Gastroenterol       Date:  2020-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.